These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20461842)

  • 1. Report from the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Early ART initiation improves survival in resource-limited settings.
    Friedland GH
    J Watch AIDS Clin Care; 2009 Oct; 21(10):79. PubMed ID: 20461842
    [No Abstract]   [Full Text] [Related]  

  • 2. Report from the 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. Maternal ART reduces transmission of HIV through breast-feeding.
    Fienberg J
    J Watch AIDS Clin Care; 2009 Oct; 21(10):79-80. PubMed ID: 20458803
    [No Abstract]   [Full Text] [Related]  

  • 3. Report from the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. When to start HIV treatment in infants.
    Albrecht H
    AIDS Clin Care; 2007 Oct; 19(10):82-3. PubMed ID: 18398995
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-retrovirals for treatment and prevention--time for new paradigms in our response to the HIV/AIDS epidemic?
    Abdool Karim Q; Bayer R
    Dev World Bioeth; 2013 Aug; 13(2):ii-iii. PubMed ID: 23865982
    [No Abstract]   [Full Text] [Related]  

  • 5. Report from the 5th IAS Conference on HIV Pathogenesis Treatment and Prevention.
    Sax PE
    J Watch AIDS Clin Care; 2009 Oct; 21(10):79. PubMed ID: 20461845
    [No Abstract]   [Full Text] [Related]  

  • 6. Report from Buenos Aires: the 1st IAS Conference on HIV Pathogenesis and Treatment.
    Gallant JE
    Hopkins HIV Rep; 2001 Sep; 13(5):1-7, 15. PubMed ID: 11682857
    [No Abstract]   [Full Text] [Related]  

  • 7. [Survival rate of HIV infected patients depends on CD4 count at therapy initiation].
    Blasko M
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1519. PubMed ID: 12899164
    [No Abstract]   [Full Text] [Related]  

  • 8. Report from the Tenth Retrovirus Conference. Clinical trials in resource-poor settings.
    Friedland G
    AIDS Clin Care; 2003 Apr; 15(4):31-2. PubMed ID: 12712944
    [No Abstract]   [Full Text] [Related]  

  • 9. Report from the 16th Conference on Retroviruses and Opportunistic Infections. Timing of ART initiation--still no definitive answers.
    Hicks CB
    J Watch AIDS Clin Care; 2009 Apr; 21(4):30. PubMed ID: 19544614
    [No Abstract]   [Full Text] [Related]  

  • 10. 3rd IAS conference: initial therapy, switching, and new strategies.
    Gallant JE
    Hopkins HIV Rep; 2005 Sep; 17(5):1-3, 12. PubMed ID: 16419300
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk factors for unstructured treatment interruptions and association with survival in low to middle income countries.
    McMahon JH; Spelman T; Ford N; Greig J; Mesic A; Ssonko C; Casas EC; O'Brien DP
    AIDS Res Ther; 2016; 13():25. PubMed ID: 27408611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring HIV treatment in resource-limited settings: reassuring news on the usefulness of CD4(+) cell counts.
    Fowler MG; Owor M
    J Infect Dis; 2009 May; 199(9):1255-7. PubMed ID: 19317627
    [No Abstract]   [Full Text] [Related]  

  • 13. Report from the 14th Retrovirus Conference. Antiviral therapy outcomes: large survey highlights differences and similarities worldwide.
    Friedland GH
    AIDS Clin Care; 2007 May; 19(5):38. PubMed ID: 18398987
    [No Abstract]   [Full Text] [Related]  

  • 14. New antiretroviral treatment guidelines from the IAS-USA panel.
    Labarga P; Blanco F
    AIDS Rev; 2012; 14(4):290. PubMed ID: 23390673
    [No Abstract]   [Full Text] [Related]  

  • 15. Separate goals, converging priorities: on the ethics of treatment as prevention.
    Ostmann F; Saenz C
    Dev World Bioeth; 2013 Aug; 13(2):57-62. PubMed ID: 23800304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report from the 13th retrovirus conference. Antiretroviral therapy in resource-limited settings.
    Friedland GH
    AIDS Clin Care; 2006 Apr; 18(4):38. PubMed ID: 16718883
    [No Abstract]   [Full Text] [Related]  

  • 17. Report from the 15th Retrovirus Conference. Increased risk for non-AIDS-related complications: implications for early ART.
    Henry K
    AIDS Clin Care; 2008 Apr; 20(4):27-8. PubMed ID: 19263574
    [No Abstract]   [Full Text] [Related]  

  • 18. Report from the 16th Conference on Retroviruses and Opportunistic Infections. No clinical benefit from adding IL-2 to ART.
    Henry K
    J Watch AIDS Clin Care; 2009 Apr; 21(4):29-30. PubMed ID: 19544613
    [No Abstract]   [Full Text] [Related]  

  • 19. Early initiation of antiretroviral therapy and universal HIV testing in sub-Saharan Africa: has WHO offered a milestone for HIV prevention?
    Menon S
    J Public Health Policy; 2010 Dec; 31(4):385-400. PubMed ID: 21119646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less.
    Bélec L; Bonn JP
    Future Microbiol; 2011 Nov; 6(11):1251-60. PubMed ID: 22082287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.